Yale School of Public Health joins CDC-funded Pathogen Genomics Center of Excellence
The Massachusetts Department of Public Health has selected the Yale School of Public Health (YSPH) and six other partners to make up its new Pathogen Genomics Center of Excellence, one of five such centers recently launched by the U.S. Centers for Disease Control and Prevention. With $25 million in funding over five years, the center’s goal will be to improve technologies and coordinated processes for systematically monitoring infectious diseases and emerging variants, enabling the U.S. to better prevent and respond to outbreaks.
Nathan Grubaugh honored with prestigious NIH New Innovator award
Yale School of Public Health Associate Professor Nathan Grubaugh has received a prestigious New Innovator Award from the National Institutes of Health in recognition of his potentially transformative biomedical research as a young career investigator.
Dr. Michael Cappello appointed chair of Epidemiology of Microbial Diseases Department
Dr. Michael Cappello, a professor of pediatrics at the Yale School of Medicine and a board-certified infectious diseases clinician, has been appointed chair of the Epidemiology of Microbial Diseases (EMD) Department, effective September 1, 2022.
Yale Biostatistician Heping Zhang Delivers Prestigious Neyman Lecture
Heping Zhang, the Susan Dwight Bliss Professor of Biostatistics at the Yale School of Public Health, recently delivered the prestigious 2022 Neyman Memorial Lecture presented by the Institute of Mathematical Statistics (IMS) – one of the highest honors in statistical societies.
USC study links PFAS to liver damage; YSPH scientist contributed to research
YSPH scientist Vasilis Vasiliou, Ph.D., department chair and Susan Bliss Professor of Epidemiology (Environmental Health Sciences), contributed to a new study by the University of Southern California’s Keck School of Medicine linking chemicals known as PFAS to liver damage.
Yale Study Identifies Causes of Cancers
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types. Their molecular analysis approach brings clarity to a longstanding debate over how much control humans have over developing cancer over time.
FDA Authorizes COVID Vaccine Booster Shots for Kids Aged 12 to 15 as Pediatric Cases Soar
The Food and Drug Administration has authorized COVID-19 vaccine booster shots for kids aged 12 to 15 years old, they announced Monday, as pediatric cases soar and children head back to school after the holidays.Source: People
Some Infectious Disease Specialists See COVID Approaching 'Endemic' Stage After Omicron
According to some infectious disease specialists, the COVID-19 pandemic could enter into the "endemic" stage after the rapidly spreading Omicron variant drastically increased the number of people infected by COVID-19.Source: Newsweek
Omicron Has Lower U.S. Hospitalization Rate Than Prior Covid Waves
The omicron-fueled U.S. surge in Covid-19 cases appears to be triggering a lower rate of hospitalizations than earlier waves, more evidence that the highly transmissible variant leads to milder symptoms than other strains.Source: Bloomberg